Goldfinch Bio Appoints Anthony Johnson, M.D., President and Chief Executive Officer, and Michael Broxson, Chief Business and Operating Officer

Neon Therapeutics Completes $106 Million Crossover Series B Financing

Global Blood Therapeutics Announces New Employment Inducement Grants

Eleven Biotherapeutics to Present at the LD Micro Main Event 2017

FDA Approves Foundation Medicine's FoundationOne CDxâ„¢, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics